Status:
COMPLETED
Prenatal Dex Study
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Congenital Adrenal Hyperplasia
Eligibility:
All Genders
6-15 years
Phase:
NA
Brief Summary
The classic form of 21-hydroxylase deficiency (prevalence 1/15,000) is the most common cause of congenital adrenal hyperplasia (CAH). This autosomic recessive disease is responsible for virilization o...
Eligibility Criteria
Inclusion
- Groups D+1, D+2, D-1 and D-2
- Male or female
- Patient with Congenital Adrenal Hyperplasia or sibling of a CAH patient
- Age: 6 to 15 years (at the time of inclusion)
- The subject's legal representatives have understood the information note/informed consent form, obtained answers to all their questions and have given signed, written, informed consent
- Subject with health insurance
- Group D-3 (Schoolchildren)
- Male or female
- With no connection with Congenital Adrenal Hyperplasia
- Age: 6 to 15 years (at the time of inclusion)
- The subject's legal representatives have understood the information note/informed consent form, obtained answers to all their questions and have given signed, written, informed consent
- Subject with health insurance
Exclusion
- For all groups :
- Patient/Subject with another genetic disease
- Patient/Subject with known neuropsychology disease(s)
- Patient/Subject whose mother has received another treatment during her pregnancy with possible known adverse events on the neuropsychological development of the child
Key Trial Info
Start Date :
October 4 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 13 2025
Estimated Enrollment :
354 Patients enrolled
Trial Details
Trial ID
NCT02795871
Start Date
October 4 2016
End Date
June 13 2025
Last Update
December 11 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'endocrinologie pédiatrique, CHU de Besançon
Besançon, France
2
Service d'endocrinologie pédiatrique, CHU de Bordeaux
Bordeaux, France
3
Groupement Hospitalier Est - Laboratoire d'endocrinologie moléculaire et maladies rares - Centre de biologie et de pathologie Est. 59 boulevard Pinel
Bron, France, 69677
4
Service d'endocrinologie pédiatrique, CHU de Grenoble
Grenoble, France